Sapna S. Humar, Jingqian Liu, Natalia Pinzon, Deepali Kumar, Mamatha Bhat, Les Lilly, Nazia Selzner – 4 April 2019 – Increased‐risk donor (IRD) organs make up a significant proportion of the deceased organ donor pool but may be declined by patients on the waiting list for various reasons. We conducted a survey of patients awaiting a liver transplant to determine the factors leading to the acceptance of an IRD organ as well as what strategies could increase the rate of acceptance.

Omar Bakr, Lillian Gelberg, Shinobu Seragaki, Sarah Youn, Jenna Kawamoto, Marcie Hoppe, Lisa Altman, Kristin Kopelson, Folasade P. May, Brianna Cowan, Debika Bhattacharya – 4 April 2019

Nadim Mahmud, Samantha Halpern, Rebecca Farrell, Kate Ventura, Arwin Thomasson, Heidi Lewis, Kim M. Olthoff, Matthew H. Levine, Susanna Nazarian, Vandana Khungar – 4 April 2019 – Hospital readmissions after liver transplantation (LT) are common and associated with increased morbidity and cost. High readmission rates at our center motivated a change in practice with adoption of a nurse practitioner (NP)–based posttransplant care program.

Hannah L. Paish, Lee H. Reed, Helen Brown, Mark C. Bryan, Olivier Govaere, Jack Leslie, Ben S. Barksby, Marina Garcia Macia, Abigail Watson, Xin Xu, Marco Y.W. Zaki, Laura Greaves, Julia Whitehall, Jeremy French, Steven A. White, Derek M. Manas, Stuart M. Robinson, Gabriele Spoletini, Clive Griffiths, Derek A. Mann, Lee A. Borthwick, Michael J.

Omar Bakr, Lillian Gelberg, Shinobu Seragaki, Sarah Youn, Jenna Kawamoto, Marcie Hoppe, Lisa Altman, Kristin Kopelson, Folasade P. May, Brianna Cowan, Debika Bhattacharya – 4 April 2019

Zita Galvin, Keyur Patel, Mamatha Bhat – 4 April 2019

Silvia Nardelli, Stefania Gioia, Lorenzo Ridola, Alessio Farcomeni, Manuela Merli, Oliviero Riggio – 4 April 2019

Victor Navarro, Bharathi Avula, Ikhlas Khan, Manisha Verma, Leonard Seeff, Jose Serrano, Andrew Stolz, Robert Fontana, Jawad Ahmad – 3 April 2019 – The U.S. Drug Induced Liver Injury Network assayed the contents of herbal and dietary supplements collected from patients enrolled into its prospective study. The aim was to determine the accuracy of product labels, and to identify known hepatotoxins. Using high‐performance liquid chromatography coupled with mass spectrometry to assay 272 product, 51% were found to be mislabeled; that is, to have chemical contents that did not match the label.

Anne C. Spaulding, Camilla S. Graham, Matthew J. Akiyama, Jagpreet Chhatwal, Ank E. Nijhawan, Michael H. Ninburg, Josiah D. Rich, Lara B. Strick, Lynn E. Taylor, Stacey B. Trooskin, Ryan P. Westergaard, William J. Sabol – 2 April 2019

Akiko Eguchi, Hiroshi Hasegawa, Motoh Iwasa, Yasuyuki Tamai, Keiichi Ohata, Tsuyoshi Oikawa, Takeshi Sugaya, Yoshiyuki Takei – 2 April 2019 – Liver‐type fatty acid–binding protein (L‐FABP) is a key regulator of fatty acid metabolism, but serum L‐FABP levels are not well investigated in chronic liver diseases. We aimed to elucidate the prognostic ability of serum L‐FABP in human chronic liver diseases and compare it with the albumin‐bilirubin (ALBI) score.